Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer.
Ann Oncol
; 27(6): 1062-1067, 2016 06.
Article
in En
| MEDLINE
| ID: mdl-26916096
Full text:
1
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
DNA Modification Methylases
/
DNA Methylation
/
Tumor Suppressor Proteins
/
Dacarbazine
/
DNA Repair Enzymes
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ann Oncol
Journal subject:
NEOPLASIAS
Year:
2016
Type:
Article